Left ventricular thrombi in the presence of normal left ventricular function

Indian Heart Journal

Volumn 54, Issue 2, 2002, Pages 196-198

  Sivasankaran, S ^a   Harikrishnan, S ^a   Tharakan, J M ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Anticardiolipin antibody; Echocardiography; Thrombus

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HUMAN; MALE; PHYSIOLOGY; THROMBOSIS;

ADOLESCENT; ADULT; ANTICOAGULANTS; ECHOCARDIOGRAPHY; HEART DISEASES; HEART VENTRICLES; HUMANS; MALE; THROMBOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0036490271     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Asherson RA, Harris EN. Anticardiolipin antibodies - clinical associations. Postgrad Med J 1986; 62: 1081-1087
2. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374
3. Biswas S, Basu D. The antiphospholipid syndrome - an overview. In: Manotosh Panja (ed). Medicine Update 2000; 11: 227-237
4. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311
5. Matitiau A, Tabachnik E, Sthoeger D, Birk E. Thrombus in the left ventricle of a child with systemic emboli: an unusual presentation of hereditary protein C deficiency. Pediatrics 2001; 107: 421-422
6. Stoddard MF, Pearson AC, Kanter KR, Labovitz AJ. Left ventricular thrombus with normal left ventricular wall motion in a patient with myelofibrosis. Am Heart J 1989; 117: 966-968
7. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97: 78-92
8. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-1600
9. Davies J, Spry CJ, Sapsford R, Olsen EG, de Perez G, Oakley CM, et al. Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med 1983; 52: 23-39
10. Peter FW, Glenn JB. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759-2779
11. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol 2000; 86: 110-113
12. Vaganos SA, Fox KR, Kitchen JG 3rd. Left ventricular thrombus in the absence of detectable heart disease. Chest 1989; 96: 426-427
13. Nahass GT, Antiphospholipid antibodies and the antiphospholipid antibody syndrome. J Am Acad Dermatol 1997; 36: 149-168: quiz 169-172
14. Hayashi S, Isobe M, Okubo Y, Suzuki J, Yazaki Y, Sekiguchi M. Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens. Heart Vessels 1999: 14: 104-108
15. Butman SM. Rapid resolution of a massive left ventricular thrombus by usual systemic anticoagulation. Am Heart J 1991; 122: 864-866